Sex hormones, related compounds and hormonal contraceptives including miscellaneous hormones

[1]  X. Dang,et al.  Severe hyponatraemia with neurological manifestations in patients treated with terlipressin: Two case reports , 2019, Journal of clinical pharmacy and therapeutics.

[2]  P. Costanzo,et al.  Testosterone Replacement Therapy and the Risk of Hypoglycemia , 2019, Case reports in endocrinology.

[3]  Y. Ansari,et al.  Sternoclavicular Joint Septic Arthritis and Anterior Mediastinal Mass in a Young Athlete: Possible Immune-modulatory Effect of Growth Hormone , 2019, Cureus.

[4]  A. Nelson.  Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, patient controlled, reversible birth control method , 2019, Expert review of clinical pharmacology.

[5]  T. Takeichi,et al.  A case of pustular psoriasis possibly precipitated by periodic oestrogen/gestagen therapy for Turner syndrome , 2019, Clinical and experimental dermatology.

[6]  G. F. Jackson,et al.  Case report of sudden death in a twin infant given melatonin supplementation: A challenging interpretation of postmortem toxicology. , 2019, Forensic science international.

[7]  A. Gonzalez-Estrada,et al.  Documented exogenous progesterone hypersensitivity related to the use of combined oral contraceptive , 2019, BMJ Case Reports.

[8]  Paul M. Boylan,et al.  Upper Gastrointestinal Bleeding in a Male Patient Taking Megestrol Acetate and Rivaroxaban: A Case Report. , 2019, The Senior care pharmacist.

[9]  E. Turillazzi,et al.  Immunodeficiency as a side effect of anabolic androgenic steroid abuse: a case of necrotizing myofasciitis , 2019, Forensic Science, Medicine and Pathology.

[10]  C. Nielsen,et al.  Hormonal contraceptive use and Staphylococcus aureus nasal and throat carriage in a Norwegian youth population , 2019, PloS one.

[11]  Li Wan,et al.  Uterine hypertonus and fetal bradycardia occurred after combined spinal-epidural analgesia during induction of labor with oxytocin infusion , 2019, Medicine.

[12]  Tian Li,et al.  Hypernatremia induced by low-dose Tolvaptan in a Patient with refractory heart failure , 2019, Medicine.

[13]  Aysha Aslam,et al.  Tolvaptan-induced Liver Injury: Who is at Risk? A Case Report and Literature Review , 2019, Cureus.

[14]  A. Haseeb,et al.  Ischemic Skin Necrosis in Hepatorenal Syndrome Patient Secondary to Terlipressin. , 2019, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[15]  N. Lakhi,et al.  Autoimmune progesterone dermatitis following vaginal progesterone exposure in pregnancy , 2019, Obstetric medicine.

[16]  S. Gaillard,et al.  Local myofascitis: An unusual adverse reaction to lanreotide autogel injection , 2019, Annales d'Endocrinologie.

[17]  Josie Smith,et al.  Hepatocellular carcinoma in body builders; an emerging rare but serious complication of androgenic anabolic steroid use , 2019, Annals of hepato-biliary-pancreatic surgery.

[18]  E. Mendel,et al.  Rapid Development of Spinal Epidural Lipomatosis after Treatment of Metastatic Castration-resistant Prostate Cancer with Second-Generation Androgen Receptor Antagonists. , 2019, World neurosurgery.

[19]  U. Bang,et al.  Hepatotoxicity induced by a second-generation combined oral contraceptive: case report and review of the literature , 2019, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[20]  B. Jee,et al.  Adverse symptoms during short‐term use of ulipristal acetate in women with uterine myomas and/or adenomyosis , 2019, The journal of obstetrics and gynaecology research.

[21]  Małgorzata Wójcik,et al.  Secondary Adrenal Insufficiency due to Intra-articular Glucocorticoid Injections , 2019, Indian Pediatrics.

[22]  M. Cutolo,et al.  Primary antiphospholipid syndrome during aromatase inhibitors therapy , 2019, Medicine.

[23]  J. Yamamura,et al.  Localized Cutaneous Adverse Event Induced by Anastrozole as Adjuvant Treatment for Breast Cancer: A Case Report , 2019, Case Reports in Dermatology.

[24]  G. Bigras,et al.  Tamoxifen induced non‐purpuric cutaneous leukocytoclastic vasculitis , 2019, The breast journal.

[25]  S. Birch,et al.  Ergometrine-induced atrial fibrillation at caesarean section , 2019, BMJ Case Reports.

[26]  T. Arnason,et al.  Bilateral osteonecrosis of the hip in panhypopituitarism , 2019, BMJ Case Reports.

[27]  H. Larjava,et al.  Large pregnancy-associated pyogenic granuloma: a case report , 2019, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[28]  S. Froelich,et al.  Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report , 2019, Acta Neurochirurgica.

[29]  S. Loibl,et al.  Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis , 2019, British Journal of Cancer.

[30]  T. Hirano,et al.  Pheochromocytoma presenting with severe hyperglycemia and metabolic acidosis following intra-articular glucocorticoid administration: a case report , 2019, Journal of Medical Case Reports.

[31]  Yaw-Bin Huang,et al.  Terlipressin-Induced Peripheral Cyanosis in a Patient with Liver Cirrhosis and Hepatorenal Syndrome , 2019, The American journal of case reports.

[32]  S. Oscoz-Jaime,et al.  Respuesta de la dermatitis autoinmune por progesterona al acetato de ulipristal , 2019, Actas Dermo-Sifiliográficas.

[33]  A. Pikula,et al.  Ischemic Stroke in a Transgender Woman Receiving Estrogen Therapy , 2019, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[34]  Minhee Lee,et al.  Posterior reversible encephalopathy syndrome in a woman who used gonadotropin-releasing hormone agonists: a case report , 2018, Obstetrics & gynecology science.

[35]  S. Lai,et al.  Tamoxifen use correlates with increased risk of hip fractures in older women with breast cancer: A case–control study in Taiwan , 2018, Geriatrics & gerontology international.

[36]  O. Franco,et al.  The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review , 2018, Human reproduction update.

[37]  J. Jeong,et al.  Two cases of primary cutaneous nocardiosis caused by intralesional injection , 2018, Dermatologic therapy.

[38]  Christina Wang,et al.  Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11&bgr;-Methyl-19-Nortestosterone-17&bgr;-Dodecylcarbonate in Men , 2018, The Journal of clinical endocrinology and metabolism.

[39]  N. Katoh,et al.  Subcutaneous nodules at progesterone injection sites after fertility treatment , 2018, The Australasian journal of dermatology.

[40]  J. F. Arevalo,et al.  HORMONAL SUPPLEMENTATION TRIGGERING CHOROIDAL NEOVASCULARIZATION IN HEALTHY YOUNG FEMALES , 2017, Retinal cases & brief reports.

[41]  Julio Calvete-Candenas,et al.  Fulvestrant-induced toxic epidermal necrolysis. , 2019, Anais brasileiros de dermatologia.

[42]  Y. Bozkaya,et al.  A rare case: Branch retinal vein occlusion associated with the use of tamoxifen , 2019, Journal of cancer research and therapeutics.